Professor David H. Vesole, MD, PhD, FACP is Co-Chief, Myeloma Division, Director,
Myeloma Research at the John Theurer Cancer Center at Hackensack UMC;
Professor of Medicine at Georgetown University School of Medicine and Hackensack
Meridian School of Medicine; Director, Myeloma Program, Medstar Georgetown University
Hospital. He is a Member of the Stem Cell Transplant & Cellular Immunotherapy
Program at both Hackensack UMC and Medstar Georgetown University Hospital.
Dr. Vesole’s research interests involve all aspects of the management of plasma cell
dyscrasias (multiple myeloma, monoclonal gammopathy of undetermined significance,
amyloidosis, Waldenstrom’s macroglolinemia). Dr. Vesole has had more than 30 years
of clinical research experience in plasma cell dyscrasias, stem cell transplant and now
effector cell therapy: he has over 250 peer reviewed publications in these areas.
He is a member of the International Myeloma Working Group and listed
in the IWMF Directory of WM Physicians.
Dr. Vesole earned his bachelor of sciences degree at the University of Iowa; PhD
degree in Immunology and Microbiology at the Medical University of South Carolina, his
medical degree at Northwestern University and completed his hematology/oncology
fellowship at the University of Iowa.
